表紙:血液製剤の世界市場の分析:製品(全血、血液成分、血液派生物)、抗血栓剤・抗凝固剤、用途別の予測 2019年~2026年
市場調査レポート
商品コード
851707

血液製剤の世界市場の分析:製品(全血、血液成分、血液派生物)、抗血栓剤・抗凝固剤、用途別の予測 2019年~2026年

Blood Preparation Market Size, Share & Trends Analysis Report By Product (Whole Blood, Blood Components, Blood Derivatives), Antithrombotic And Anticoagulants Type, By Application, And Segment Forecasts, 2019 - 2026

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 110 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.86円
血液製剤の世界市場の分析:製品(全血、血液成分、血液派生物)、抗血栓剤・抗凝固剤、用途別の予測 2019年~2026年
出版日: 2019年04月18日
発行: Grand View Research, Inc.
ページ情報: 英文 110 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血液製剤市場は、2019年から2026年にかけて5.6%のCAGRで推移し、2026年までに567億8,000万米ドル規模の市場に成長すると予測されています。血液成分および輸血の需要の増加と血液関連疾患の有病率の上昇が当市場の成長を促進する見込みです。

当レポートでは、世界の血液製剤市場を調査し、市場の概要、セグメント・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 調査方法と範囲

  • 市場区分と範囲
  • 情報調達
  • 情報分析
  • 市場形成とデータの可視化
  • データ検証と公開

第2章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
  • 競争の考察

第3章 市場変数、動向、範囲

  • 浸透および成長の見通しのマッピング
  • 製品パイプライン分析
  • 償還の枠組み
  • 市場力学
  • 分析ツール
  • PESTEL分析

第4章 血液製剤の世界市場:製品別

  • 市場の定義と範囲
  • 市場シェア:製品別(実績値・予測値)
  • 製品ダッシュボード
  • 市場分析:製品別
  • 市場規模の推移と予測:製品別
  • 全血
    • 赤血球
    • 顆粒球
    • プラズマ
    • 血小板
  • 血液成分
    • 全血成分
    • 赤血球
    • 白血球減少赤血球
    • 凍結プラズマ
    • 血小板濃縮物
    • クリオ製剤
  • 血液派生物

第5章 抗血栓剤および抗凝固剤の世界市場:種類別

  • 市場の定義と範囲
  • 市場シェア:種類別(実績値・予測値)
  • 製品ダッシュボード
  • 市場分析:種類別
  • 市場規模の推移と予測:種類別
  • 血小板凝集抑制剤
    • 糖タンパク質阻害剤
    • COX阻害剤
    • ADPアンタゴニスト
    • その他
  • 線維素溶解剤
    • 組織プラスミノーゲンアクチベーター(tPA)
    • ストレプトキナーゼ
    • ウロキナーゼ
  • 抗凝固剤
    • ヘパリン
    • ビタミンK拮抗剤
    • 直接トロンビン阻害剤
    • 直接第Xa因子阻害剤

第6章 抗血栓剤および抗凝固剤の世界市場:用途別

  • 市場の定義と範囲
  • 市場シェア:用途別(実績値・予測値)
  • 製品ダッシュボード
  • 市場分析:用途別
  • 市場規模の推移と予測:用途別
  • 血小板増加症
  • 肺塞栓症
  • 腎機能障害
  • 狭心症血管合併症
  • その他

第7章 血液製剤の世界市場:地域別

  • 市場スナップショット:地域別
  • 市場シェアと主要企業:地域別
  • SWOT分析
  • 市場規模、市場予測、動向分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • 中南米
  • 中東・アフリカ

第8章 抗血栓剤および抗凝固剤の世界市場:地域別

  • 市場スナップショット:地域別
  • 市場シェアと主要企業:地域別
  • SWOT分析
  • 市場規模、市場予測、動向分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • 中南米
  • 中東・アフリカ

第9章 企業プロファイル

  • GlaxoSmithKline plc
  • Pfizer, Inc
  • Bristol-Myers Squibb Company
  • Leo Pharma A/S
  • Sanofi
  • Xiamen Hisunny Chemical Co., LTD
  • AstraZeneca plc
  • Baxter International Inc
図表

List of Tables

  • TABLE 1 List of Abbreviation
  • TABLE 2 North America Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 3 North America Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 4 North America Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 5 U.S. Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 6 U.S. Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 7 U.S. Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 8 Canada Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 9 Canada Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 10 Canada Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 11 North America Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 12 North America Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 13 North America Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 14 North America Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 15 North America Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 16 North America Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 17 U.S. Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 18 U.S. Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 19 U.S. Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 20 U.S. Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 21 U.S. Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 22 U.S. Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 23 Canada Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 24 Canada Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 25 Canada Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 -2026 (USD Million)
  • TABLE 26 Canada Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 27 Canada Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 28 Canada Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 29 Europe Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 30 Europe Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 31 Europe Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 32 Germany Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 33 Germany Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 34 Germany Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 35 France Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 36 France Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 37 France Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 38 U.K Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 39 U.K Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 40 U.K Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 41 Italy Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 42 Italy Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 43 Italy Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 44 Spain Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 45 Spain Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 46 Spain Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 47 Russia Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 48 Russia Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 49 Russia Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 50 Europe Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 51 Europe Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 52 Europe Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 53 Europe Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 54 Europe Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 55 Europe Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 56 Germany Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 57 Germany Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 58 Germany Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 59 Germany Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 60 Germany Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 61 Germany Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 62 France Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 63 France Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 64 France Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 65 France Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 66 France Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 67 France Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 68 U.K Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 69 U.K Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 70 U.K Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 71 U.K Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 72 U.K Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 73 U.K Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 74 Italy Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 75 Italy Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 76 Italy Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 77 Italy Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 78 Italy Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 79 Italy Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 80 Spain Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 81 Spain Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 82 Spain Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 83 Spain Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 84 Spain Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 85 Spain Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 86 Russia Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 87 Russia Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 88 Russia Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 89 Russia Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 90 Russia Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 91 Russia Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 92 Asia Pacific Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 93 Asia Pacific Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 94 Asia Pacific Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 95 Japan Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 96 Japan Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 97 Japan Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 98 China Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 99 China Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 100 China Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 101 India Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 102 India Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 103 India Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 104 South Korea Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 105 South Korea Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 106 South Korea Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 107 Australia Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 108 Australia Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 109 Australia Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 110 Singapore Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 111 Singapore Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 112 Singapore Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 113 Asia Pacific Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 114 Asia Pacific Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 115 Asia Pacific Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 116 Asia Pacific Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 117 Asia Pacific Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 118 Asia Pacific Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 119 Japan Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 120 Japan Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 121 Japan Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 122 Japan Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 123 Japan Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 124 Japan Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 125 China Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 126 China Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 127 China Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 128 China Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 129 China Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 130 China Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 131 India Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 132 India Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 133 India Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 134 India Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 135 India Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 136 India Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 137 South Korea Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 138 South Korea Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 139 South Korea Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 2026 (USD Million)
  • TABLE 140 South Korea Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 141 South Korea Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 142 South Korea Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 143 Australia Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 144 Australia Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 145 Australia Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 146 Australia Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 147 Australia Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 148 Australia Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 149 Singapore Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 150 Singapore Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 151 Singapore Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 152 Singapore Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 153 Singapore Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 154 Singapore Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 155 Latin America Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 156 Latin America Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 157 Latin America Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 158 Brazil Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 159 Brazil Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 160 Brazil Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 161 Mexico Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 162 Mexico Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 163 Mexico Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 164 Argentina Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 165 Argentina Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 166 Argentina Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 167 Latin America Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 168 Latin America Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 169 Latin America Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 -2026 (USD Million)
  • TABLE 170 Latin America Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 171 Latin America Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 172 Latin America Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 173 Brazil Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 174 Brazil Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 175 Brazil Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 176 Brazil Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 177 Brazil Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 178 Brazil Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 179 Mexico Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 180 Mexico Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 181 Mexico Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 182 Mexico Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 183 Mexico Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 184 Mexico Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 185 Argentina Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 186 Argentina Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 187 Argentina Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 188 Argentina Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 189 Argentina Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 190 Argentina Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 191 MEA Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 192 MEA Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 193 MEA Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 194 South Africa Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 195 South Africa Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 196 South Africa Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 197 Saudi Arabia Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 198 Saudi Arabia Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 199 Saudi Arabia Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 200 UAE Blood Preparation Market, by Product, 2014 - 2026 (USD Million)
  • TABLE 201 UAE Blood Preparation Market, by Whole Blood, 2014 - 2026 (USD Million)
  • TABLE 202 UAE Blood Preparation Market, by Blood Components, 2014 - 2026 (USD Million)
  • TABLE 203 MEA Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 204 MEA Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 205 MEA Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 206 MEA Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 207 MEA Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 208 MEA Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 209 South Africa Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 210 South Africa Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 211 South Africa Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 212 South Africa Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 213 South Africa Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 214 South Africa Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 215 Saudi Arabia Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 216 Saudi Arabia Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 217 Saudi Arabia Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 -2026 (USD Million)
  • TABLE 218 Saudi Arabia Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 219 Saudi Arabia Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 220 Saudi Arabia Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)
  • TABLE 221 UAE Antithrombotic & Anticoagulants Market, by Type, 2014 - 2026 (USD Million)
  • TABLE 222 UAE Antithrombotic & Anticoagulants Market, by Application, 2014 - 2026 (USD Million)
  • TABLE 223 UAE Antithrombotic & Anticoagulants Market, by Platelet Aggregation Inhibitors, 2014 - 2026 (USD Million)
  • TABLE 224 UAE Antithrombotic & Anticoagulants Market, by Fibrinolytics, 2014 - 2026 (USD Million)
  • TABLE 225 UAE Antithrombotic & Anticoagulants Market, by Anticoagulants, 2014 - 2026 (USD Million)
  • TABLE 226 UAE Antithrombotic & Anticoagulants Market, by Heparin, 2014 - 2026 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Market summary
  • FIG. 4 Market segmentation & scope
  • FIG. 5 Market size and growth prospects
  • FIG. 6 Global blood preparation - Key market driver analysis
  • FIG. 7 Global blood preparation market - Key market restraint analysis
  • FIG. 8 Penetration & growth prospect mapping
  • FIG. 9 Global blood preparation market - Porter's analysis
  • FIG. 10 Global blood preparation market - PESTEL analysis
  • FIG. 11 Global blood preparation market product outlook key takeaways
  • FIG. 12 Global blood preparation market: product movement analysis
  • FIG. 13 Whole blood market estimates, 2014 - 2026 (USD Million)
  • FIG. 14 Red cells market estimates, 2014 - 2026 (USD Million)
  • FIG. 15 Granulocytes market estimates, 2014 - 2026 (USD Million)
  • FIG. 16 Plasma market estimates, 2014 - 2026 (USD Million)
  • FIG. 17 Platelets market estimates, 2014 - 2026 (USD Million)
  • FIG. 18 Whole blood components market estimates, 2014 - 2026 (USD Million)
  • FIG. 19 Packed red cells market estimates, 2014 - 2026 (USD Million)
  • FIG. 20 Leukocyte reduced red blood cells market estimates, 2014 - 2026 (USD Million)
  • FIG. 21 Frozen plasma market estimates, 2014 - 2026 (USD Million)
  • FIG. 22 Platelet concentrate market estimates, 2014 - 2026 (USD Million)
  • FIG. 23 Cryoprecipitate market estimates, 2014 - 2026 (USD Million)
  • FIG. 24 Blood derivatives market estimates, 2014 - 2026 (USD Million)
  • FIG. 25 Global Antithrombotic & anticoagulants market type outlook key takeaways
  • FIG. 26 Global Antithrombotic & anticoagulants market: type movement analysis
  • FIG. 27 Platelet aggregation inhibitors market estimates, 2014 - 2026 (USD Million)
  • FIG. 28 Glycoprotein Inhibitors market estimates, 2014 - 2026 (USD Million)
  • FIG. 29 COX Inhibitors market estimates, 2014 - 2026 (USD Million)
  • FIG. 30 ADP Antagonists market estimates, 2014 - 2026 (USD Million)
  • FIG. 31 Others market estimates, 2014 - 2026 (USD Million)
  • FIG. 32 Fibrinolytics market estimates, 2014 - 2026 (USD Million)
  • FIG. 33 Tissue Plasminogen Activator (tPA) market estimates, 2014 - 2026 (USD Million)
  • FIG. 34 Streptokinase market estimates, 2014 - 2026 (USD Million)
  • FIG. 35 Urokinase market estimates, 2014 - 2026 (USD Million)
  • FIG. 36 Anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 37 Heparins market, 2014 - 2026 (USD Million)
  • FIG. 38 Unfractionated Heparin market, 2014 - 2026 (USD Million)
  • FIG. 39 Low Molecular Weight Heparin (LMWH) market, 2014 - 2026 (USD Million)
  • FIG. 40 Ultra-low Molecular Weight Heparin market, 2014 - 2026 (USD Million)
  • FIG. 41 Vitamin K Antagonists market, 2014 - 2026 (USD Million)
  • FIG. 42 Direct Thrombin Inhibitors market, 2014 - 2026 (USD Million)
  • FIG. 43 Direct Factor Xa Inhibitors market, 2014 - 2026 (USD Million)
  • FIG. 44 Global blood preparation regional market place: Key takeaways
  • FIG. 45 Global blood preparation market: Regional movement analysis
  • FIG. 46 North America blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 47 U.S. blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 48 Europe blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 49 Germany blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 50 France blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 51 U.K blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 52 Italy blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 53 Spain blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 54 Russia blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 55 Asia Pacific blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 56 Japan blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 57 China blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 58 India blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 59 South Korea blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 60 Australia blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 61 Singapore blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 62 Latin America blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 63 Brazil blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 64 Mexico blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 65 Argentina blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 66 MEA blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 67 South Africa blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 68 UAE blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 69 Saudi Arabia blood preparation market, 2014 - 2026 (USD Million)
  • FIG. 70 Global Antithrombotic & anticoagulants regional market place: Key takeaways
  • FIG. 71 Global Antithrombotic & anticoagulants market: Regional movement analysis
  • FIG. 72 North America Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 73 U.S. Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 74 Europe Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 75 Germany Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 76 France Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 77 U.K Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 78 Italy Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 79 Spain Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 80 Russia Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 81 Asia Pacific Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 82 Japan Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 83 China Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 84 India Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 85 South Korea Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 86 Australia Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 87 Singapore Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 88 Latin America Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 89 Brazil Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 90 Mexico Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 91 Argentina Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 92 MEA Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 93 South Africa Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 94 UAE Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
  • FIG. 95 Saudi Arabia Antithrombotic & anticoagulants market, 2014 - 2026 (USD Million)
目次
Product Code: 978-1-68038-455-0

The global blood preparation market size is expected to reach USD 56.78 billion by 2026 registering a CAGR of 5.6%, according to a new report by Grand View Research, Inc. Demand for transfusion of blood and its components and increasing prevalence of blood-related disorders are expected to fuel the growth of this market over the forecast period.

Increasing prevalence of thrombocytosis-associated disorders is also likely to boost market growth. According to the Centers for Disease Control and Prevention (CDC), around 900,000 individuals are affected by Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in U.S. each year, and 60,000-100,000 Americans die due to DVT/PE. Commercialization of drugs currently in the pipeline and introduction of new oral anticoagulants are expected to drive the market further.

Anticoagulants was the largest product segment in 2018 owing to increased R&D aimed at the development of novel prophylactic and therapeutic drugs. Re-launch of some key drug products, such as Urokinase in North America, are also likely to propel market growth over the coming years.

The market in Asia Pacific is also anticipated to witness high growth in future, owing to the presence of favorable government initiatives, sophisticated healthcare infrastructure, especially in Japan and Australia, and several untapped opportunities in the emerging markets of China and India.

Further key findings from the study suggest:

  • Whole blood product segment held the largest share in 2018 due increased number of surgeries and trauma cases
  • Blood derivatives is estimated to be the fastest-growing segment due to use of these products in patients affected with infectious diseases, such as Ebola
  • Anticoagulants dominated the antithrombotic and anticoagulants product segment and are likely to witness the fastest CAGR of 5.8% due to launch of novel and efficient anticoagulant drugs in market
  • The direct factor Xa inhibitors is the most lucrative segment on account of the introduction of new oral products, such as Xarelto, aimed at addressing unmet medical needs
  • Angina blood vessel complications was the largest application segment due to rise in lifestyle-associated diseases and popularity of oral anticoagulants
  • North America was the largest regional blood preparation market in 2018 and will maintain the dominance over the forecast years
  • Presence of sophisticated healthcare infrastructure along with high patient awareness and healthcare expenditure levels in North America will drive the regional market

Key companies in the market include: GlaxoSmithKline PLC; Pfizer, Inc.; Baxter International, Inc.; Bristol-Myers Squibb Company; LEO Pharma A/S; Sanofi S.A.; Portola Pharmaceuticals, Inc.; and AstraZeneca PLC

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market segmentation & scope
  • 1.2. Market definition
  • 1.3. Information procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources & third party perspectives
    • 1.3.4. Primary research
  • 1.4. Information analysis
    • 1.4.1. Data analysis models
  • 1.5. Market formulation & data visualization
  • 1.6. Data validation & publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Blood Preparation Market Variables, Trends & Scope

  • 3.1. Penetration & Growth Prospect Mapping
  • 3.2. Product Pipeline Analysis, by Stage
  • 3.3. Reimbursement Framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
  • 3.5. Blood Preparation Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier Power: Moderate
      • 3.5.1.2. Buyer Power: Moderate
      • 3.5.1.3. Substitution Threat: Low
      • 3.5.1.4. Threat from new entrant: High
      • 3.5.1.5. Competitive rivalry: High
  • 3.6. PESTEL Analysis
    • 3.6.1. Political Landscape
    • 3.6.2. Environmental Landscape
    • 3.6.3. Social Landscape
    • 3.6.4. Technology Landscape
    • 3.6.5. Legal Landscape

Chapter 4. Blood Preparation Market: Product Estimates & Trend Analysis

  • 4.1. Definitions & Scope
  • 4.2. Product market share analysis, 2018 & 2026
  • 4.3. Product Dashboard
  • 4.4. Global Blood Preparation Market, by Product, 2014 to 2026
  • 4.5. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
  • 4.6. Whole Blood
    • 4.6.1. Whole blood market, 2014 - 2026 (USD Million)
    • 4.6.2. Red Cells
      • 4.6.2.1. Red cells market, 2014 - 2026 (USD Million)
    • 4.6.3. Granulocytes
      • 4.6.3.1. Granulocytes market, 2014 - 2026 (USD Million)
    • 4.6.4. Plasma
      • 4.6.4.1. Plasma market, 2014 - 2026 (USD Million)
    • 4.6.5. Platelets
      • 4.6.5.1. Platelets market, 2014 - 2026 (USD Million)
  • 4.7. Blood Components
    • 4.7.1. Whole Blood Components
      • 4.7.1.1. Whole blood components market, 2014 - 2026 (USD Million)
    • 4.7.2. Packed Red Cells
      • 4.7.2.1. Packed red cells market, 2014 - 2026 (USD Million)
    • 4.7.3. Leukocyte Reduced Red Blood Cells
      • 4.7.3.1. Leukocyte reduced red blood cells market, 2014 - 2026 (USD Million)
    • 4.7.4. Frozen Plasma
      • 4.7.4.1. Frozen plasma market, 2014 - 2026 (USD Million)
    • 4.7.5. Platelet Concentrate
      • 4.7.5.1. Plasma concentrate market, 2014 - 2026 (USD Million)
    • 4.7.6. Cryoprecipitate
      • 4.7.6.1. Cryoprecipitate market, 2014 - 2026 (USD Million)
  • 4.8. Blood Derivatives
    • 4.8.1. Blood derivatives market, 2014 - 2026 (USD Million)

Chapter 5. Antithrombotic and Anticoagulants Market: Type Estimates & Trend Analysis

  • 5.1. Definitions & Scope
  • 5.2. Type market share analysis, 2018 & 2026
  • 5.3. Type Dashboard
  • 5.4. Global Antithrombotic and Anticoagulants Market, by Type, 2014 to 2026
  • 5.5. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
  • 5.6. Platelet Aggregation Inhibitors
    • 5.6.1. Platelet aggregation inhibitors market, 2014 - 2026 (USD Million)
    • 5.6.2. Glycoprotein Inhibitors
      • 5.6.2.1. Glycoprotein inhibitors market, 2014 - 2026 (USD Million)
    • 5.6.3. COX Inhibitors
      • 5.6.3.1. COX inhibitors market, 2014 - 2026 (USD Million)
    • 5.6.4. ADP Antagonists
      • 5.6.4.1. ADP antagonists market, 2014 - 2026 (USD Million)
    • 5.6.5. Others
      • 5.6.5.1. Others market, 2014 - 2026 (USD Million)
  • 5.7. Fibrinolytics
    • 5.7.1. Fibrinolytics market, 2014 - 2026 (USD Million)
    • 5.7.2. Tissue Plasminogen Activator (tPA)
      • 5.7.2.1. Tissue Plasminogen Activator (tPA) market, 2014 - 2026 (USD Million)
    • 5.7.3. Streptokinase
      • 5.7.3.1. Streptokinase market, 2014 - 2026 (USD Million)
    • 5.7.4. Urokinase
      • 5.7.4.1. Urokinase market, 2014 - 2026 (USD Million)
  • 5.8. Anticoagulants
    • 5.8.1. Anticoagulants market, 2014 - 2026 (USD Million)
    • 5.8.2. Heparins
      • 5.8.2.1. Heparins market, 2014 - 2026 (USD Million)
      • 5.8.2.2. Unfractionated Heparin
      • 5.8.2.2.1. Unfractionated heparins market, 2014 - 2026 (USD Million)
      • 5.8.2.3. Low Molecular Weight Heparin (LMWH)
      • 5.8.2.3.1. Low Molecular Weight Heparin (LMWH) market, 2014 - 2026 (USD Million)
      • 5.8.2.4. Ultra-low Molecular Weight Heparin
      • 5.8.2.4.1. Ultra-low Molecular Weight Heparin market, 2014 - 2026 (USD Million)
    • 5.8.3. Vitamin K antagonists
      • 5.8.3.1. Vitamin K antagonists market, 2014 - 2026 (USD Million)
    • 5.8.4. Direct thrombin inhibitors
      • 5.8.4.1. Direct thrombin inhibitors market, 2014 - 2026 (USD Million)
    • 5.8.5. Direct factor Xa inhibitors
      • 5.8.5.1. Direct factor Xa inhibitors market, 2014 - 2026 (USD Million)

Chapter 6. Antithrombotic and Anticoagulants Market: Application Estimates & Trend Analysis

  • 6.1. Definitions & Scope
  • 6.2. Application market share analysis, 2018 & 2026
  • 6.3. Application Dashboard
  • 6.4. Global Antithrombotic and Anticoagulants Market, by Application, 2014 to 2026
  • 6.5. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
  • 6.6. Thrombocytosis
    • 6.6.1. Thrombocytosis market, 2014 - 2026 (USD Million)
  • 6.7. Pulmonary embolism
    • 6.7.1. Pulmonary embolism market, 2014 - 2026 (USD Million)
  • 6.8. Renal impairment
    • 6.8.1. Renal impairment market, 2014 - 2026 (USD Million)
  • 6.9. Angina blood vessel complications
    • 6.9.1. Angina blood vessel complications market, 2014 - 2026 (USD Million)
  • 6.10. Others
    • 6.10.1. Others market, 2014 - 2026 (USD Million)

Chapter 7. Blood Preparation Market: Regional Estimates & Trend analysis, by product,

  • 7.1. Regional Market Snapshot
  • 7.2. Regional Market Share and Leading Players, 2018 & 2026
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. Middle East & Africa
  • 7.3. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia Pacific
    • 7.3.4. Latin America
    • 7.3.5. Middle East & Africa
  • 7.4. Market Size, & Forecasts, and Trend Analysis, 2018 to 2026:
  • 7.5. North America
    • 7.5.1. North America market, 2014 - 2026 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. U.S. market, 2014 - 2026 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Canada market, 2014 - 2026 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe market, 2014 - 2026 (USD Million)
    • 7.6.2. U.K.
      • 7.6.2.1. U.K. market, 2014 - 2026 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Germany market, 2014 - 2026 (USD Million)
    • 7.6.4. Spain
      • 7.6.4.1. Spain market, 2014 - 2026 (USD Million)
    • 7.6.5. France
      • 7.6.5.1. France market, 2014 - 2026 (USD Million)
    • 7.6.6. Italy
      • 7.6.6.1. Italy market, 2014 - 2026 (USD Million)
    • 7.6.7. Russia
      • 7.6.7.1. Russia market, 2014 - 2026 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific market, 2014 - 2026 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. China market, 2014 - 2026 (USD Million)
    • 7.7.3. Japan
      • 7.7.3.1. Japan market, 2014 - 2026 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. India market, 2014 - 2026 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. South Korea market, 2014 - 2026 (USD Million)
    • 7.7.6. Singapore
      • 7.7.6.1. Singapore market, 2014 - 2026 (USD Million)
    • 7.7.7. Australia
      • 7.7.7.1. Australia market, 2014 - 2026 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America market, 2014 - 2026 (USD Million)
    • 7.8.2. Brazil
      • 7.8.2.1. Brazil market, 2014 - 2026 (USD Million)
    • 7.8.3. Mexico
      • 7.8.3.1. Mexico market, 2014 - 2026 (USD Million)
    • 7.8.4. Argentina
      • 7.8.4.1. Argentina market, 2014 - 2026 (USD Million)
  • 7.9. Middle East & Africa
    • 7.9.1. Middle East & Africa market, 2014 - 2026 (USD Million)
    • 7.9.2. South Africa
      • 7.9.2.1. South Africa market, 2014 - 2026 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Saudi Arabia market, 2014 - 2026 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. UAE market, 2014 - 2026 (USD Million)

Chapter 8. Antithrombotic and Anticoagulants Market: Regional Estimates & Trend analysis, by type & application,

  • 8.1. Regional Market Snapshot
  • 8.2. Regional Market Share and Leading Players, 2018
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
    • 8.3.1. North America
    • 8.3.2. Europe
    • 8.3.3. Asia Pacific
    • 8.3.4. Latin America
    • 8.3.5. Middle East & Africa
  • 8.4. Market Size, & Forecasts, and Trend Analysis, 2018 to 2026:
  • 8.5. North America
    • 8.5.1. North America market, 2014 - 2026 (USD Million)
    • 8.5.2. U.S.
      • 8.5.2.1. U.S. market, 2014 - 2026 (USD Million)
    • 8.5.3. Canada
      • 8.5.3.1. Canada market, 2014 - 2026 (USD Million)
  • 8.6. Europe
    • 8.6.1. Europe market, 2014 - 2026 (USD Million)
    • 8.6.2. UK
      • 8.6.2.1. UK market, 2014 - 2026 (USD Million)
    • 8.6.3. Germany
      • 8.6.3.1. Germany market, 2014 - 2026 (USD Million)
    • 8.6.4. Spain
      • 8.6.4.1. Spain market, 2014 - 2026 (USD Million)
    • 8.6.5. France
      • 8.6.5.1. France market, 2014 - 2026 (USD Million)
    • 8.6.6. Italy
      • 8.6.6.1. Italy market, 2014 - 2026 (USD Million)
    • 8.6.7. Russia
      • 8.6.7.1. Russia market, 2014 - 2026 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Asia Pacific market, 2014 - 2026 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. China market, 2014 - 2026 (USD Million)
    • 8.7.3. Japan
      • 8.7.3.1. Japan market, 2014 - 2026 (USD Million)
    • 8.7.4. India
      • 8.7.4.1. India market, 2014 - 2026 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. South Korea market, 2014 - 2026 (USD Million)
    • 8.7.6. Singapore
      • 8.7.6.1. Singapore market, 2014 - 2026 (USD Million)
    • 8.7.7. Australia
      • 8.7.7.1. Australia market, 2014 - 2026 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Latin America market, 2014 - 2026 (USD Million)
    • 8.8.2. Brazil
      • 8.8.2.1. Brazil market, 2014 - 2026 (USD Million)
    • 8.8.3. Mexico
      • 8.8.3.1. Mexico market, 2014 - 2026 (USD Million)
    • 8.8.4. Argentina
      • 8.8.4.1. Argentina market, 2014 - 2026 (USD Million)
  • 8.9. Middle East & Africa
    • 8.9.1. Middle East & Africa market, 2014 - 2026 (USD Million)
    • 8.9.2. South Africa
      • 8.9.2.1. South Africa market, 2014 - 2026 (USD Million)
    • 8.9.3. Saudi Arabia
      • 8.9.3.1. Saudi Arabia market, 2014 - 2026 (USD Million)
    • 8.9.4. UAE
      • 8.9.4.1. UAE market, 2014 - 2026 (USD Million)

Chapter 9. Company Profiles

  • 9.1. Strategic Framework
    • 9.1.1. GlaxoSmithKline plc
      • 9.1.1.1. Company overview
      • 9.1.1.2. Financial framework
      • 9.1.1.3. Product benchmarking
      • 9.1.1.4. Strategic initiatives
    • 9.1.2. Pfizer, Inc
      • 9.1.2.1. Company overview
      • 9.1.2.2. Financial framework
      • 9.1.2.3. Product benchmarking
      • 9.1.2.4. Strategic initiatives
    • 9.1.3. Bristol-Myers Squibb Company
      • 9.1.3.1. Company overview
      • 9.1.3.2. Financial framework
      • 9.1.3.3. Product benchmarking
      • 9.1.3.4. Strategic initiatives
    • 9.1.4. Leo Pharma A/S
      • 9.1.4.1. Company overview
      • 9.1.4.2. Financial framework
      • 9.1.4.3. Product benchmarking
      • 9.1.4.4. Strategic initiatives
    • 9.1.5. Sanofi
      • 9.1.5.1. Company overview
      • 9.1.5.2. Financial framework
      • 9.1.5.3. Product benchmarking
      • 9.1.5.4. Strategic initiatives
    • 9.1.6. Xiamen Hisunny Chemical Co., LTD
      • 9.1.6.1. Company overview
      • 9.1.6.2. Financial framework
      • 9.1.6.3. Product benchmarking
      • 9.1.6.4. Strategic initiatives
    • 9.1.7. AstraZeneca plc
      • 9.1.7.1. Company overview
      • 9.1.7.2. Financial framework
      • 9.1.7.3. Product benchmarking
      • 9.1.7.4. Strategic initiatives
    • 9.1.8. Baxter International Inc
      • 9.1.8.1. Company overview
      • 9.1.8.2. Financial framework
      • 9.1.8.3. Product benchmarking
      • 9.1.8.4. Strategic initiatives